Onderneming AstraZeneca PLC Nasdaq

AZN

US0463531089

Farmaceutische producten

Analistenconsensus

Vakgebied

Verkoop per activiteit

Verkoop per regio

Managers

Besturend

Aandelenklasse

Aandeelhouders

Participaties

Bedrijfsgegevens

Bedrijven van de groep

Sector

Verkoop per activiteit

Verkoop per regio

Ratings voor AstraZeneca PLC

Herzieningen van WPA

Kwartaalwinst - Afwijkingspercentage

Sector Farmaceutische producten - Andere

Beurs gesloten - Nasdaq Andere beurzen 22:00:00 30-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
75,88 ^USD	+0,53%		+7,10%	+12,67%

30/04	FTC vecht 'rommelige' octrooilijsten aan voor Ozempic, Victoza, andere medicijnen	MT
30/04	ASTRAZENECA : Deutsche Bank herhaalt Neutraal advies	ZD

AstraZeneca PLC is een van de grootste farmaceutische groepen ter wereld. De nettoverkoop kan als volgt worden uitgesplitst naar inkomstenbron
- productverkoop (95,6%). De nettoverkoop wordt per behandelingsgebied verdeeld tussen oncologie (39,2%), hart- en vaatziekten, nierziekten en stofwisselingsziekten (24,2%), ademhalings- en auto-immuunziekten (13,9%), en overige (22,7%; ontstekingsziekten, neurologische ziekten, maag-, darm- en infectieziekten);
- inkomsten uit samenwerking (4,4%).
De netto-omzet is als volgt geografisch verdeeld: het Verenigd Koninkrijk (7,4%), Europa (21,2%), Amerika (45,3%) en Afrika-Azië-Australië (26,1%).

Aantal werknemers: 89 900

GBP in miljoen	2022	Gewicht	2023	Gewicht	Delta
Oncology 37,4 %	11 878	33,0 %	13 793	37,4 %	+16,12%
Cardiovascular, Renal and Metabolism 23,1 %	7 459	20,7 %	8 515	23,1 %	+14,16%
Rare Disease 16,9 %	5 726	15,9 %	6 246	16,9 %	+9,08%
Respiratory and Immunology 13,3 %	4 680	13,0 %	4 913	13,3 %	+4,97%
Alliance 3,1 %	-	-	1 149	3,1 %	-
Other Medicines 2,6 %	1 319	3,7 %	946	2,6 %	-28,29%
Vaccines and Immune Therapies 2,2 %	3 845	10,7 %	814	2,2 %	-78,83%
Collaboration 1,3 %	1 098	3,1 %	478	1,3 %	-56,50%

GBP in miljoen	2022	Gewicht	2023	Gewicht	Delta
United States 39,6 %	14 027	39,0 %	14 578	39,6 %	+3,93%
China 12,8 %	4 662	12,9 %	4 724	12,8 %	+1,32%
Japan 7,9 %	3 236	9,0 %	2 928	7,9 %	-9,51%
United Kingdom 7,4 %	2 530	7,0 %	2 709	7,4 %	+7,07%
Other Rest of Europe 6,8 %	2 197	6,1 %	2 502	6,8 %	+13,89%
Germany 4,6 %	1 544	4,3 %	1 689	4,6 %	+9,36%
Other Asia, Africa and Australasia 4,5 %	1 953	5,4 %	1 645	4,5 %	-15,77%
Sweden 3,7 %	1 397	3,9 %	1 371	3,7 %	-1,89%
Other Americas 3,7 %	954	2,6 %	1 354	3,7 %	+41,94%
France 2,5 %	899	2,5 %	927	2,5 %	+3,12%
Canada 2,1 %	947	2,6 %	778	2,1 %	-17,82%
Spain 1,8 %	599	1,7 %	681	1,8 %	+13,73%
Italy 1,8 %	597	1,7 %	654	1,8 %	+9,61%
Australia 0,9 %	464	1,3 %	314	0,9 %	-32,32%

Managers	Titel	Leeftijd	Van
Pascal Soriot CEO	Chief Executive Officer	64	01-10-12
Aradhana Sarin DFI	Director of Finance/CFO	50	01-08-21
Cindy Hoots CTO	Chief Tech/Sci/R&D Officer	56	01-01-20
Sharon Barr CTO	Chief Tech/Sci/R&D Officer	-	01-08-23
Regina Danielson CTO	Chief Tech/Sci/R&D Officer	60	-
Alberto Hegewisch CTO	Chief Tech/Sci/R&D Officer	-	18-05-23
Pam Cheng COO	Chief Operating Officer	53	01-06-15
Jeffrey Pott CMP	Compliance Officer	-	01-01-95
Margareta Elisabeth Björk PRN	Corporate Officer/Principal	63	01-01-02
Iskra Reic PRN	Corporate Officer/Principal	-	01-01-01

Besturend	Titel	Leeftijd	Van
Sherilyn McCoy BRD	Director/Board Member	65	01-10-17
Ahmed Hamdy PRN	Corporate Officer/Principal	59	01-02-13
Philip Broadley BRD	Director/Board Member	63	27-04-17
Marcus Wallenberg BRD	Director/Board Member	68	01-04-99
Marc Dunoyer PRN	Corporate Officer/Principal	71	01-06-13
Andreas Rummelt BRD	Director/Board Member	66	01-08-21
Michel Demaré CHM	Chairman	67	01-09-19
Pascal Soriot CEO	Chief Executive Officer	64	01-10-12
Deborah DiSanzo BRD	Director/Board Member	64	01-12-17
Aradhana Sarin DFI	Director of Finance/CFO	50	01-08-21

	Stemming	Aantal	Vrij verhandelbaar	Bedrijfseigen aandelen	Drijvend Totaal
Aandeel A	1	1 550 162 626	1 495 897 151 ( 96,50 %)	0	96,50 %

Naam	Aandelen	%	Totale waarde
BlackRock Investment Management (UK) Ltd. 4,420 %	68 512 693	4,420 %	9 242 M $
Wellington Management Co. LLP 4,201 %	65 120 892	4,201 %	8 784 M $
The Vanguard Group, Inc. 3,593 %	55 698 000	3,593 %	7 513 M $
Investor AB (Investment Company) 3,328 %	51 587 810	3,328 %	6 959 M $
Norges Bank Investment Management 2,216 %	34 357 000	2,216 %	4 634 M $
BlackRock Fund Advisors 1,918 %	29 736 171	1,918 %	4 011 M $
BlackRock Advisors (UK) Ltd. 1,418 %	21 987 529	1,418 %	2 966 M $
Swedbank Robur Fonder AB 1,096 %	16 986 070	1,096 %	2 291 M $
Legal & General Investment Management Ltd. 0,9998 %	15 499 242	0,9998 %	2 091 M $
BlackRock Advisors LLC 0,9901 %	15 349 305	0,9901 %	2 070 M $

Naam	Aandelen	%	Totale waarde
T. Rowe Price International Ltd. 1,686 %	52 269 524	1,686 %	3 541 M $
Wellington Management Co. LLP 1,595 %	49 444 180	1,595 %	3 350 M $
PRIMECAP Management Co. 1,386 %	42 987 075	1,386 %	2 912 M $
Capital Research & Management Co. (International Investors) 1,122 %	34 782 762	1,122 %	2 357 M $
Fidelity Management & Research Co. LLC 0,6877 %	21 321 999	0,6877 %	1 445 M $
Jennison Associates LLC 0,5719 %	17 732 542	0,5719 %	1 201 M $
Sanders Capital LLC 0,4736 %	14 684 066	0,4736 %	995 M $
GQG Partners LLC 0,4470 %	13 858 383	0,4470 %	939 M $
Eaton Vance Management 0,4041 %	12 530 160	0,4041 %	849 M $
Merrill Lynch International 0,3772 %	11 695 224	0,3772 %	792 M $

Naam	Aandelen	%	Totale waarde
Caixa DTVM SA 0,002924 %	272 113	0,002924 %	3 M $

Naam	Aandelen	%	Totale waarde
ASTRAZENECA PHARMA INDIA LIMITED 75.00%	18 750 000	75.00%	1 196 097 188 $
SWEDISH ORPHAN BIOVITRUM AB 9.06%	32 100 518	9.06%	802 167 869 $
DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD. 37.58%	108 923 023	37.58%	678 032 747 $
NIOX GROUP PLC 16.81%	71 065 878	16.81%	57 455 341 $
CELLECTIS S.A. 22.30%	16 000 000	22.30%	42 992 640 $
ADC THERAPEUTICS SA 4.86%	4 011 215	4.86%	18 010 355 $
INNATE PHARMA 9.26%	7 485 500	9.26%	17 664 283 $
PIERIS PHARMACEUTICALS, INC. 3.63%	3 584 230	3.63%	655 914 $
ARIDIS PHARMACEUTICALS, INC. 1.99%	884 956	1.99%	69 027 $

AstraZeneca PLC

Cambridge Biomedical Campus 1 Francis Crick Avenue

CB2 0AA, Cambridge

+44 20 3749 5000

http://www.astrazeneca.co.uk

Naam	Categorie en sector
AstraZeneca AB AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden.	Miscellaneous Commercial Services
ASTRAZENECA PHARMA INDIA LIMITED	Pharmaceuticals: Major
AstraZeneca UK Ltd. AstraZeneca UK Ltd. Miscellaneous Commercial ServicesCommercial Services AstraZeneca UK Ltd. manufactures pharmaceutical products. Its products are used to treat cardiovascular diseases, diabetes, and gastrointestinal infections. The company was founded on November 26, 1998 and is headquartered in London, the United Kingdom.	Miscellaneous Commercial Services
R&Q Beta Co. Plc R&Q Beta Co. Plc Insurance Brokers/ServicesFinance R&Q Beta Co. Plc provides insurance services. The company was founded in 1994 and is headquartered in Cambridge, the United Kingdom.	Insurance Brokers/Services
AstraZeneca India Pvt Ltd. AstraZeneca India Pvt Ltd. Pharmaceuticals: MajorHealth Technology AstraZeneca India Pvt Ltd. operates as a biopharmaceutical company. The company was founded in 1979 and is headquartered in Bangalore, India.	Pharmaceuticals: Major
Astrazeneca Holdings BV
AstraZeneca Share Trust Ltd. AstraZeneca Share Trust Ltd. Miscellaneous Commercial ServicesCommercial Services Part of AstraZeneca PLC, AstraZeneca Share Trust Ltd. is a British company that provides business support services. The private company is located in the UK.	Miscellaneous Commercial Services
AstraZeneca Employee Share Trust Ltd. AstraZeneca Employee Share Trust Ltd. Miscellaneous Commercial ServicesCommercial Services Part of AstraZeneca PLC, AstraZeneca Employee Share Trust Ltd. is a British company that provides business support services. The private company is located in the UK.	Miscellaneous Commercial Services
Astrazeneca Treasury BV
Astrazeneca Finance & Holdings, Inc. Astrazeneca Finance & Holdings, Inc. Financial ConglomeratesFinance Part of AstraZeneca PLC, Astrazeneca Finance & Holdings, Inc. is an investment holding American company. The private company is located in the US.	Financial Conglomerates
AstraZeneca Finance LLC	Finance/Rental/Leasing
Alexion Pharmaceuticals, Inc. /New/
Astrazeneca Treasury Ltd. Astrazeneca Treasury Ltd. Financial ConglomeratesFinance Part of AstraZeneca PLC, AstraZeneca Treasury Ltd. functions as an investment holding British company. The private company is based in Cambridge, UK.	Financial Conglomerates

Trading rating

Beleggingsrating

ESG Refinitiv

Meer adviezen

Verkoop

Koop

Gemiddeld advies

Kopen

Aantal analisten

Laatste slotkoers

151,1 USD

Gemiddelde koersdoel

164,3 USD

Spread / Gemiddelde doel

+8,74%

Consensus

Bedrijfscijfers

De agenda van het bedrijf

Gezondheidszorg

Farmaceutisch en medisch onderzoek

Farmaceutische producten

Farmaceutische producten

Farmaceutische producten - Andere

	Vaira. 1 jan.	Kapi.
ELI LILLY AND COMPANY	+34,00%	704 mld.
NOVO NORDISK A/S	+29,29%	577 mld.
JOHNSON & JOHNSON	-7,75%	348 mld.
MERCK & CO., INC.	+18,53%	327 mld.
ABBVIE INC.	+4,95%	288 mld.
NOVARTIS AG	+4,93%	198 mld.
ROCHE HOLDING AG	-9,78%	194 mld.
AMGEN INC.	-4,89%	147 mld.
PFIZER, INC.	-11,01%	145 mld.

Farmaceutische producten - Andere